Colombo D, Ammirati E (2011) Cyclosporine in transplantation - a history of converging timelines. J Biol Regul Homeost Agents 25(4):493–504

CAS  PubMed  Google Scholar 

Subramani MV, Pandit S, Gadre SK (2022) Acute rejection and post lung transplant surveillance. Indian J Thorac Cardiovasc Surg 38:271–279. https://doi.org/10.1007/S12055-021-01320-Z

Article  PubMed  PubMed Central  Google Scholar 

de Silva T, Voisey J, Hopkins P et al (2022) Markers of rejection of a lung allograft: State of the art. Biomark Med 16(6):483–498. https://doi.org/10.2217/BMM-2021-1013

Article  CAS  PubMed  Google Scholar 

Barbarino JM, Staatz CE, Venkataramanan R et al (2013) PharmGKB summary: Cyclosporine and tacrolimus pathways. Pharmacogenet Genomics 23(10):563–585. https://doi.org/10.1097/FPC.0B013E328364DB84

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bennett D, Fossi A, Marchetti L et al (2019) Postoperative acute kidney injury in lung transplant recipients. Interact Cardiovasc Thorac Surg 28(6):929–935. https://doi.org/10.1093/ICVTS/IVY355

Article  PubMed  Google Scholar 

Kong Q, Gao N, Wang Y et al (2023) Functional evaluation of cyclosporine metabolism by CYP3A4 variants and potential drug interactions. Front Pharmacol. https://doi.org/10.3389/FPHAR.2022.1044817

Article  PubMed  PubMed Central  Google Scholar 

Boscolo A, Dell’Amore A, Pettenuzzo T et al (2022) The Impact of New Treatments on Short- and MID-Term Outcomes in Bilateral Lung Transplant: A Propensity Score Study. J Clin Med. https://doi.org/10.3390/JCM11195859

Article  PubMed  PubMed Central  Google Scholar 

Fan Y, Xiao YB, Weng YG (2009) Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis. Transplant Proc 41(5):1821–1824. https://doi.org/10.1016/j.transproceed.2008.11.016

Article  CAS  PubMed  Google Scholar 

Penninga L, Penninga EI, Møller CH et al (2013) Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD008817.PUB2

Article  PubMed  PubMed Central  Google Scholar 

Higgins JPT, Thomas J, Chandler J et al (2019) Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Handbook for Systematic Reviews of Interventions. https://doi.org/10.1002/9781119536604

Article  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, The PRISMA et al (2020) statement: An updated guideline for reporting systematic reviews. The BMJ 2021:372. https://doi.org/10.1136/BMJ.N71

Article  Google Scholar 

Sterne JAC, Savović J, Page MJ et al (2019) RoB 2: A revised tool for assessing risk of bias in randomised trials. The BMJ. https://doi.org/10.1136/BMJ.L4898

Article  PubMed  PubMed Central  Google Scholar 

Guyatt GH, Oxman AD, Kunz R et al (2008) What is “quality of evidence” and why is it important to clinicians? BMJ 336(7651):995–998. https://doi.org/10.1136/bmj.39490.551019.BE

Article  PubMed  PubMed Central  Google Scholar 

Review Manager (RevMan) [Computer program]. Version 5.4. The Cochrane Collaboration. 2020

Thorlund K, Engstrøm J, Wetterslev J et al. User Manual for Trial Sequential Analysis (TSA). Copenhagen: Copenhagen Trial Unit, Centre for Clinical Intervention Research; 2011:1–115. Available from: www.ctu.dk/tsa

Dellgren G, Lund TK, Raivio P et al (2024) Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial. Lancet Respir Med 12(1):34–44. https://doi.org/10.1016/S2213-2600(23)00293-X

Article  CAS  PubMed  Google Scholar 

Hachem RR, Yusen RD, Chakinala MM et al (2007) A Randomized Controlled Trial of Tacrolimus Versus Cyclosporine After Lung Transplantation. J Heart Lung Transplant 26(10):1012–1018. https://doi.org/10.1016/J.HEALUN.2007.07.027

Article  PubMed  Google Scholar 

Treede H, Glanville AR, Klepetko W et al (2012) Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: Results of a prospective, randomized international trial in lung transplantation. J Heart Lung Transplant 31(8):797–804. https://doi.org/10.1016/J.HEALUN.2012.03.008

Article  PubMed  Google Scholar 

Zuckermann A, Reichenspurner H, Birsan T et al (2003) Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: One-year results of a 2-center prospective randomized trial. J Thorac Cardiovasc Surg 125(4):891–900. https://doi.org/10.1067/MTC.2003.71

Article  CAS  PubMed  Google Scholar 

Lund LH, Edwards LB, Kucheryavaya AY et al (2015) The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report - 2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant 34(10):1244–1254. https://doi.org/10.1016/J.HEALUN.2015.08.003

Article  PubMed  Google Scholar 

Hachem RR, Khalifah AP, Chakinala MM et al (2005) The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation 80(10):1406–1413. https://doi.org/10.1097/01.TP.0000181161.60638.FA

Article  PubMed  Google Scholar 

Darley DR, Carlos L, Hennig S et al (2019) Tacrolimus exposure early after lung transplantation and exploratory associations with acute cellular rejection. Eur J Clin Pharmacol 75(7):879–888. https://doi.org/10.1007/S00228-019-02658-5

Article  CAS  PubMed  Google Scholar 

Horning NR, Lynch JP, Sundaresan SR et al (1998) Tacrolimus therapy for persistent or recurrent acute rejection after lung transplantation. J Heart Lung Transplant 17(8):761–767

CAS  PubMed  Google Scholar 

Martinu T, Pavlisko EN, Chen DF, Palmer SM (2011) Acute allograft rejection: cellular and humoral processes. Clin Chest Med 32(2):295–310. https://doi.org/10.1016/j.ccm.2011.02.008

Article  PubMed  PubMed Central  Google Scholar 

Meiser BM, Uberfuhr P, Fuchs A et al (1997) Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation. J Heart Lung Transplant 16(8):795–800

CAS  PubMed  Google Scholar 

Maes BD, Vanrenterghem YFC (2004) Cyclosporine: Advantages versus disadvantages vis-à-vis tacrolimus. Transpl Proc 36(2 SUPPL.):S40–S49. https://doi.org/10.1016/J.TRANSPROCEED.2004.01.038

Article  Google Scholar 

Haddad EM, McAlister VC, Renouf E et al (2006) Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD005161.PUB2

Article  PubMed  PubMed Central  Google Scholar 

Kim SJ, Lee KW, Lee DS et al (2004) Randomized trial of tacrolimus versus cyclosporine in steroid withdrawal in living donor renal transplant recipients. Transpl Proc 36(7):2098–2100. https://doi.org/10.1016/J.TRANSPROCEED.2004.08.070

Article  CAS  Google Scholar 

Staatz CE, Tett SE (2004) Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet 43(10):623–653. https://doi.org/10.2165/00003088-200443100-00001

Article  CAS  PubMed  Google Scholar 

Naesens M, Kuypers DRJ, Sarwal M (2009) Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 4(2):481–508. https://doi.org/10.2215/CJN.04800908

Article  CAS  PubMed  Google Scholar 

Morales JM, Andres A, Rengel M et al (2001) Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation. Nephrol Dial Transplant 16(SUPPL. 1):121–124. https://doi.org/10.1093/NDT/16.SUPPL_1.121

Article  CAS  PubMed  Google Scholar 

Weir MR, Burgess ED, Cooper JE et al (2015) Assessment and management